Cargando…
Persistence of High Percentage of Peripheral Activated CD8+ T Cells Predict Cytologic HPV-Related Dysplasia in cART-Treated, HIV-Positive Subjects
BACKGROUND: People with HIV are at increased risk of human papillomavirus (HPV) disease progression, given the persistence of immune activation and residual inflammation despite effective combination antiretroviral therapy (cART). Whether a low CD4:CD8 T-cell ratio, known to mirror peripheral immune...
Autores principales: | Mondatore, Debora, Bai, Francesca, Augello, Matteo, Giovenzana, Marco, Pisani Ceretti, Andrea, Bono, Valeria, Opocher, Enrico, d’Arminio Monforte, Antonella, Marchetti, Giulia Carla, Tincati, Camilla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918388/ https://www.ncbi.nlm.nih.gov/pubmed/35291446 http://dx.doi.org/10.1093/ofid/ofac046 |
Ejemplares similares
-
Do Combination Antiretroviral Therapy Regimens for HIV Infection Feature Diverse T-Cell Phenotypes and Inflammatory Profiles?
por: Tincati, Camilla, et al.
Publicado: (2020) -
Long-Term Suppressive cART Is Not Sufficient to Restore Intestinal Permeability and Gut Microbiota Compositional Changes
por: Ancona, Giuseppe, et al.
Publicado: (2021) -
Predictors of low ovarian reserve in cART-treated women living with HIV
por: Merlini, Esther, et al.
Publicado: (2021) -
Six-month immune responses to mRNA-1273 vaccine in combination antiretroviral therapy treated late presenter people with HIV according to previous SARS-CoV-2 infection
por: Augello, Matteo, et al.
Publicado: (2023) -
Mucosal cell populations may contribute to peripheral immune abnormalities in HIV-infected subjects introducing cART with moderate immune-suppression
por: Basilissi, Matteo, et al.
Publicado: (2019)